ID   PDE9A_RAT               Reviewed;         534 AA.
AC   Q8QZV1; F1LRG6;
DT   27-MAY-2015, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   29-MAY-2024, entry version 140.
DE   RecName: Full=High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305};
DE            EC=3.1.4.35 {ECO:0000250|UniProtKB:O76083};
GN   Name=Pde9a {ECO:0000312|RGD:621035};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11698617; DOI=10.1523/jneurosci.21-22-09068.2001;
RA   Andreeva S.G., Dikkes P., Epstein P.M., Rosenberg P.A.;
RT   "Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain.";
RL   J. Neurosci. 21:9068-9076(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=14501210; DOI=10.1023/a:1025704031210;
RA   van Staveren W.C., Glick J., Markerink-van Ittersum M., Shimizu M.,
RA   Beavo J.A., Steinbusch H.W., de Vente J.;
RT   "Cloning and localization of the cGMP-specific phosphodiesterase type 9 in
RT   the rat brain.";
RL   J. Neurocytol. 31:729-741(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-318, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [6]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=18674549; DOI=10.1016/j.neuropharm.2008.07.005;
RA   van der Staay F.J., Rutten K., Baerfacker L., Devry J., Erb C.,
RA   Heckroth H., Karthaus D., Tersteegen A., van Kampen M., Blokland A.,
RA   Prickaerts J., Reymann K.G., Schroeder U.H., Hendrix M.;
RT   "The novel selective PDE9 inhibitor BAY 73-6691 improves learning and
RT   memory in rodents.";
RL   Neuropharmacology 55:908-918(2008).
RN   [7]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=22070409; DOI=10.3109/01677063.2011.630494;
RA   Vardigan J.D., Converso A., Hutson P.H., Uslaner J.M.;
RT   "The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates
RT   a scopolamine-induced deficit in a novel rodent attention task.";
RL   J. Neurogenet. 25:120-126(2011).
RN   [8]
RP   FUNCTION.
RX   PubMed=22328573; DOI=10.1124/jpet.111.191353;
RA   Kleiman R.J., Chapin D.S., Christoffersen C., Freeman J., Fonseca K.R.,
RA   Geoghegan K.F., Grimwood S., Guanowsky V., Hajos M., Harms J.F.,
RA   Helal C.J., Hoffmann W.E., Kocan G.P., Majchrzak M.J., McGinnis D.,
RA   McLean S., Menniti F.S., Nelson F., Roof R., Schmidt A.W., Seymour P.A.,
RA   Stephenson D.T., Tingley F.D., Vanase-Frawley M., Verhoest P.R.,
RA   Schmidt C.J.;
RT   "Phosphodiesterase 9A regulates central cGMP and modulates responses to
RT   cholinergic and monoaminergic perturbation in vivo.";
RL   J. Pharmacol. Exp. Ther. 341:396-409(2012).
CC   -!- FUNCTION: Specifically hydrolyzes the second messenger cGMP, which is a
CC       key regulator of many important physiological processes. Highly
CC       specific: compared to other members of the cyclic nucleotide
CC       phosphodiesterase family, has the highest affinity and selectivity for
CC       cGMP. Specifically regulates natriuretic-peptide-dependent cGMP
CC       signaling in heart, acting as a regulator of cardiac hypertrophy in
CC       myocytes and muscle. Does not regulate nitric oxide-dependent cGMP in
CC       heart. Additional experiments are required to confirm whether its
CC       ability to hydrolyze natriuretic-peptide-dependent cGMP is specific to
CC       heart or is a general feature of the protein (By similarity). In brain,
CC       involved in cognitive function, such as learning and long-term memory
CC       (PubMed:18674549, PubMed:22070409, PubMed:22328573).
CC       {ECO:0000250|UniProtKB:O76083, ECO:0000269|PubMed:18674549,
CC       ECO:0000269|PubMed:22070409, ECO:0000269|PubMed:22328573}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP + H2O = GMP + H(+); Xref=Rhea:RHEA:16957,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57746,
CC         ChEBI:CHEBI:58115; EC=3.1.4.35;
CC         Evidence={ECO:0000250|UniProtKB:O76083};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:O76083};
CC       Note=Binds 1 Zn(2+) ion per subunit. Binds 2 divalent metal cations per
CC       subunit: site 1 preferentially binds zinc, while site 2 has a
CC       preference for magnesium. Tightly binds zinc.
CC       {ECO:0000250|UniProtKB:O76083};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O76083};
CC       Note=Binds 1 Mg(2+) ions per subunit. Binds 2 divalent metal cations
CC       per subunit: site 1 preferentially binds zinc, while site 2 has a
CC       preference for magnesium. Binds magnesium less tightly than zinc.
CC       {ECO:0000250|UniProtKB:O76083};
CC   -!- ACTIVITY REGULATION: Specifically inhibited by BAY-73-6691 (1-(2-
CC       chlorophenyl)-6-((2R)-3,3,3- trifluoro-2-methylpropyl)-1,5-dihydro-4H-
CC       pyrazolo(3,4-d)pyrimidine-4-one) (PubMed:18674549). Specifically
CC       inhibited by PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-
CC       ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-
CC       pyrazolo[3,4-d]pyrimidin-4-one) (PubMed:22070409).
CC       {ECO:0000269|PubMed:18674549, ECO:0000269|PubMed:22070409}.
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from
CC       3',5'-cyclic GMP: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:O76083}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, ruffle membrane
CC       {ECO:0000250|UniProtKB:O76083}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:O76083}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:O76083}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:O76083}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:O76083}.
CC   -!- TISSUE SPECIFICITY: Widely expressed in brain: highly expressed in the
CC       basal forebrain, cerebellum and olfactory bulb (PubMed:11698617,
CC       PubMed:14501210). Expressed at highest level in cerebellar Purkinje
CC       cells (PubMed:14501210). {ECO:0000269|PubMed:11698617,
CC       ECO:0000269|PubMed:14501210}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       PDE9 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF372654; AAL99404.1; -; mRNA.
DR   EMBL; AY145898; AAN64274.1; -; mRNA.
DR   EMBL; AABR06100132; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06100133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06100134; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06100135; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC161837; AAI61837.1; -; mRNA.
DR   RefSeq; NP_612552.1; NM_138543.1.
DR   RefSeq; XP_008771015.1; XM_008772793.2.
DR   RefSeq; XP_008771016.1; XM_008772794.2.
DR   RefSeq; XP_008771017.1; XM_008772795.2.
DR   AlphaFoldDB; Q8QZV1; -.
DR   SMR; Q8QZV1; -.
DR   STRING; 10116.ENSRNOP00000001559; -.
DR   BindingDB; Q8QZV1; -.
DR   ChEMBL; CHEMBL3638358; -.
DR   iPTMnet; Q8QZV1; -.
DR   PhosphoSitePlus; Q8QZV1; -.
DR   PaxDb; 10116-ENSRNOP00000001559; -.
DR   Ensembl; ENSRNOT00000001559.8; ENSRNOP00000001559.7; ENSRNOG00000001174.8.
DR   Ensembl; ENSRNOT00065045265; ENSRNOP00065037122; ENSRNOG00065026086.
DR   GeneID; 191569; -.
DR   KEGG; rno:191569; -.
DR   UCSC; RGD:621035; rat.
DR   AGR; RGD:621035; -.
DR   CTD; 5152; -.
DR   RGD; 621035; Pde9a.
DR   eggNOG; KOG3689; Eukaryota.
DR   GeneTree; ENSGT00940000155587; -.
DR   HOGENOM; CLU_032104_1_0_1; -.
DR   InParanoid; Q8QZV1; -.
DR   OMA; HPGFNNY; -.
DR   OrthoDB; 5479253at2759; -.
DR   PhylomeDB; Q8QZV1; -.
DR   TreeFam; TF314638; -.
DR   BRENDA; 3.1.4.35; 5301.
DR   Reactome; R-RNO-418457; cGMP effects.
DR   UniPathway; UPA00763; UER00748.
DR   PRO; PR:Q8QZV1; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000001174; Expressed in jejunum and 18 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; ISS:UniProtKB.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IBA:GO_Central.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IBA:GO_Central.
DR   GO; GO:0046069; P:cGMP catabolic process; ISS:UniProtKB.
DR   GO; GO:0046068; P:cGMP metabolic process; ISS:UniProtKB.
DR   GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IMP:RGD.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISS:UniProtKB.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   CDD; cd00077; HDc; 1.
DR   Gene3D; 1.10.1300.10; 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR11347:SF230; HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A; 1.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF109604; HD-domain/PDEase-like; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; cGMP; Cytoplasm; Endoplasmic reticulum;
KW   Golgi apparatus; Hydrolase; Magnesium; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Zinc.
FT   CHAIN           1..534
FT                   /note="High affinity cGMP-specific 3',5'-cyclic
FT                   phosphodiesterase 9A"
FT                   /id="PRO_0000433157"
FT   DOMAIN          175..496
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   REGION          500..534
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        518..534
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        251
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         251..255
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         255
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         291
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         292
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         292
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         292
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         401
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         401
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         423
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         451..452
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
SQ   SEQUENCE   534 AA;  61756 MW;  4AB9382BA2D2CB54 CRC64;
     MGAGSSSYRP KAIYLDIDGR IQKVVFSKYC NSSDIMDLFC IATGLPRNTT ISLLTTDDAM
     VSIDPTMPAN SERTPYKVRP VAVKQVSERE ELVQGVLAQV AEQFSRAFKI NELKAEVANH
     LAMLEKRVEL EGLKVVEIEK CKSDIKKMRE ELAARNNRTN CPCKYSFLDN KKLTPRRDVP
     TYPKYLLSPE TIEALRKPTF DVWLWEPNEM LSCLEHMYHD LGLVRDFSIN PITLRRWLLC
     VHDNYRSNPF HNFRHCFCVT QMMYSMVWLC GLQEKFSQMD ILVLMTAAIC HDLDHPGYNN
     TYQINARTEL AVRYNDISPL ENHHCAIAFQ ILARPECNIF ASVPPEGFRQ IRQGMITLIL
     ATDMARHAEI MDSFKEKMEN FDYSNEEHLT LLKMILIKCC DISNEVRPME VAEPWVDCLL
     EEYFMQSDRE KSEGLPVAPF MDRDKVTKAT AQIGFIKFVL IPMFETVTKL FPIVEETMLR
     PLWESREHYE ELKQLDDAMK ELQKKTENLT SGATENAPEK TRDAKDNEDR SPPN
//
